University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries

Simple item page
dc.contributor.authorMichelsen, Brigitte
dc.contributor.authorGeorgiadis, Stylianos
dc.contributor.authorDi Giuseppe, Daniela
dc.contributor.authorLoft, Anne G
dc.contributor.authorNissen, Michael J
dc.contributor.authorIannone, Florenzo
dc.contributor.authorPombo-Suarez, Manuel
dc.contributor.authorMann, Herman
dc.contributor.authorRotar, Ziga
dc.contributor.authorEklund, Kari K
dc.contributor.authorKvien, Tore K
dc.contributor.authorSantos, Maria J
dc.contributor.authorGudbjornsson, Bjorn
dc.contributor.authorCodreanu, Catalin
dc.contributor.authorYilmaz, Sema
dc.contributor.authorWallman, Johan K
dc.contributor.authorBrahe, Cecilie H
dc.contributor.authorMöller, Burkhard
dc.contributor.authorFavalli, Ennio G
dc.contributor.authorSánchez-Piedra, Carlos
dc.contributor.authorNekvindova, Lucie
dc.contributor.authorTomsic, Matija
dc.contributor.authorTrokovic, Nina
dc.contributor.authorKristianslund, Eirik K
dc.contributor.authorSantos, Helena
dc.contributor.authorLöve, Thorvardur J
dc.contributor.authorIonescu, Ruxandra
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorJones, Gareth T
dc.contributor.authorvan der Horst-Bruinsma, Irene
dc.contributor.authorØrnbjerg, Lykke M
dc.contributor.authorØstergaard, Mikkel
dc.contributor.authorHetland, Merete L
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.date.accessioned2022-08-10T13:05:00Z
dc.date.available2022-08-10T13:05:00Z
dc.date.issued2022-07-01
dc.descriptionROLE OF THE STUDY SPONSOR Novartis had no role in the study design or in the collection, analysis, or interpretation of the data, the writing of the manuscript, or the decision to submit the manuscript for publication. Publication of this article was not contingent upon approval by Novartisen
dc.description.statusPeer revieweden
dc.format.extent14
dc.format.extent847704
dc.identifier191494127
dc.identifier064a1581-3974-4922-97cf-3f85105aadeb
dc.identifier33460531
dc.identifier000788811100001
dc.identifier85110422849
dc.identifier85110422849
dc.identifier.citationMichelsen, B, Georgiadis, S, Di Giuseppe, D, Loft, A G, Nissen, M J, Iannone, F, Pombo-Suarez, M, Mann, H, Rotar, Z, Eklund, K K, Kvien, T K, Santos, M J, Gudbjornsson, B, Codreanu, C, Yilmaz, S, Wallman, J K, Brahe, C H, Möller, B, Favalli, E G, Sánchez-Piedra, C, Nekvindova, L, Tomsic, M, Trokovic, N, Kristianslund, E K, Santos, H, Löve, T J, Ionescu, R, Pehlivan, Y, Jones, G T, van der Horst-Bruinsma, I, Ørnbjerg, L M, Østergaard, M & Hetland, M L 2022, 'Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries', Arthritis Care & Research, vol. 74, no. 7, pp. 1205-1218. https://doi.org/10.1002/acr.24560en
dc.identifier.doi10.1002/acr.24560
dc.identifier.iss7en
dc.identifier.issn0893-7524
dc.identifier.otherJisc: 4a6ebb9610b74e44960bb2dbc2171be8
dc.identifier.otherORCID: /0000-0003-0016-7591/work/101050628
dc.identifier.urihttps://hdl.handle.net/2164/19053
dc.identifier.vol74en
dc.language.isoeng
dc.relation.ispartofArthritis Care & Researchen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleReal-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countriesen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Michelsen_etal_ACR_Real_World_Six_VoR.pdf
Size:
827.84 KB
Format:
Adobe Portable Document Format
Download

Collections

All research